We first investigated the involvement of p62 in CRC patients from the TCGA dataset and identified that SQSTM1/p62 mRNA expression was significantly increased in CRC tissues compared to normal controls (Figure 1A, P < 0.001). This evidence concerns the gene SQSTM1 and colorectal carcinoma.